Overview

Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder

Status:
Completed

Trial end date:
2008-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to find out whether atomoxetine (also called Strattera) helps teenagers (12-19) with Attention Deficit Hyperactivity Disorder (ADHD) and drug/alcohol problems.

Phase:

N/A

Details

Lead Sponsor:

Denver Health and Hospital Authority

Collaborator:

American Academy of Child Adolescent Psychiatry.

Treatments:

Atomoxetine Hydrochloride